| I N TR ODU C TI ON
Immune thrombocytopenia (ITP) is a common cause of severe thrombocytopenia in dogs. 1 It occurs when antiplatelet antibodies bound to the platelet surface lead to clearance and premature platelet destruction by the reticuloendothelial system. 2, 3 Although ITP causes thrombocytopenia, not all dogs with ITP develop signs of hemorrhage and platelet count does not consistently predict bleeding risk or mortality. 4 Human ITP patients also have been shown to have heterogeneous bleeding phenotypes. One study in the human literature reported no association between platelet count and bleeding severity in patients with severe thrombocytopenia (platelet count < 30,000/lL). 5 Immunosuppressive doses of glucocorticoids are the current firstline treatment for dogs with ITP, but few evidence-based guidelines exist to dictate the timing or choice of adjunctive, second-line therapies. 4, 6, 7 Several studies have used platelet recovery as the main indicator of response to treatment. 6, 8, 9 However, treatment to attain a target platelet count has the potential to lead to over-treatment (ie, higher drug dosages and addition of adjunctive immunosuppressants that may not provide additional benefit in preventing or controlling bleeding). Corticosteroids and combined immunosuppressive drug treatment carry risks including gastrointestinal ulceration, 10 hepatotoxicity, 11 secondary infections, [12] [13] [14] and potential hypercoagulability. 15 Because platelet count alone does not reliably predict clinically relevant bleeding in canine or human ITP patients, 4 ,5 additional clinical and laboratory metrics for objectively gauging bleeding severity are needed to minimize the risk of over-treatment for an individual patient and to stratify patients for prospective clinical studies. A bleeding score metric would help to objectively assess efficacy of adjunctive therapies in multicenter clinical trials, stratify patients according to their bleeding severity, and identify laboratory variables that predict or correlate with bleeding severity.
Our primary objective was to develop a novel ITP bleeding assessment tool for dogs or "DOGiBAT" to allow more consistent and standardized quantification of bleeding severity in dogs with ITP. Other study objectives were to assess a training course designed to instruct users of the DOGiBAT on its correct implementation, and to apply the DOGiBAT in clinical cases of canine thrombocytopenia to assess the relationship between DOGiBAT and platelet count and as a preliminary evaluation of the relationship between DOGiBAT and patient outcome.
Dogs with platelet counts < 50,000/lL of any underlying etiology were included in this pilot project. We hypothesized that the use of the DOGiBAT would allow for consistent bleeding severity scoring among clinicians, and that a training course would improve less clinically experienced users' (veterinary students') ability to correctly assign bleeding severity scores. We also hypothesized that in clinical cases of thrombocytopenia in dogs, DOGiBAT score and platelet count would be inversely correlated, but that this relationship would be lost in severely thrombocytopenic dogs (platelet counts < 30,000/lL). For these cases, no consistent association between platelet count and DOGiBAT score would exist, as described for people with ITP evaluated using a comparable scoring system, 5 and based on the observed bleeding heterogeneity of severely thrombocytopenic ITP dogs. A novel daily bleeding assessment tool for dogs, the DOGiBAT, was developed for dogs with ITP (Table 1) . This tool was modeled after a scoring system designed for human ITP patients, the ITP Bleeding Scale (IBLS). 5 The DOGiBAT comprised 9 different anatomic sites (cutaneous, catheter or venipuncture bleeding, oral mucosa, intraocular, epistaxis, gastrointestinal, urinary, pulmonary, and intracranial). Each anatomic site was given a site-specific bleeding grade of 0 (none), 1 (mild), or 2 (severe), with the exception of pulmonary and intracranial, which were given only grades of 0 (absent) or 2 (suspected/present). A case-based quiz set of still images also was developed, using images from clinical cases. This case-based quiz was used to assess users' ability to correctly apply the DOGiBAT tool after they had completed the training course. We designed a standard case-based quiz to allow for consistency over time and across multiple institutions. The quiz provided the user with clinical case descriptions and images to completely score 3 canine thrombocytopenic cases using the DOGi-BAT. The complete quiz is available in the supplementary materials, along with the quiz score sheet to record answers, and the answer key to the quiz (Supporting Information Figures S2-S4 ).
| Study design
This study consisted of 3 phases, as outlined in Figure 2 . In phase 1, clinicians and technicians took the training course, after which they completed a case-based quiz to assess their ability to correctly implement the DOGiBAT.
In phase 2, equal numbers of third and fourth year veterinary student volunteers (n 5 70) were randomized (https://www.randomizer. Enrolled thrombocytopenic dogs were classified into 3 subgroups according to the underlying etiology of the thrombocytopenia, using a classification scheme similar to 1 previously described. 16 In 
| Statistical analysis
Sample size calculations were performed using online resources (OpenEpi, Atlanta, Georgia; http://www.stat.ubc.ca/~rollin/stats/ssize/b2.
html) to determine the number of students needed per group (students with access to the training course and students who were not given access to the training course) to detect a significant difference in DOGiBAT quiz score with training. Pilot data was utilized from 10 untrained veterinary students who scored 3 cases (cluster size 30) with a baseline correct response rate of 75%. Using independent samples, an alpha 5 0.05 and 80% power, the required sample size to detect a significant difference (defined as a 20% increase in number of correct scores) between the 2 groups was calculated. When sample sizes were adjusted for clustering by students (ie, each student answered multiple questions), and assuming an intraclass correlation of 0.75, the required sample size was determined to be 35 students in the trained group and 35 students in the untrained group.
For data analysis of quiz-taker performance, bleeding grades were converted to a 2-level outcome variable, where the response was considered either correct (1) or incorrect (0). Quiz site scores were con- were included in this analysis. Automated platelet counts that were reported as <10,000/lL or <20,000/lL were converted to 9,000/lL and 19,000/lL, respectively, for data analysis. To compare admission
DOGiBAT scores and platelet counts among the 3 groups of dogs (PI, SI, NI), Kruskal-Wallis tests were performed followed by pairwise comparisons with nonparametric Wilcoxon rank sum tests when differences among all 3 groups were identified. Assumptions of normality were not made. P-values < .05 were considered significant.
Spearman correlation coefficients were calculated to assess the associations between admission DOGiBAT score (at each anatomic site and total DOGiBAT score) and outcome measures, and between admission platelet count and outcome measures. Outcome measures assessed were transfusion requirements, duration of hospitalization (days), and survival to discharge. For data analysis of outcome measures, transfusion requirements and survival to discharge each were converted to a 2-level outcome variable. In the case of transfusion requirements, the outcome was whether any volume of any blood product(s) was administered during hospitalization (1) or no blood products were administered (0). For survival, the outcome was death or euthanasia while hospitalized (0) or survival to discharge from the hospital (1). Wilcoxon rank sum tests were performed to compare outcome measures between PI dogs and non-PI dogs (SI and NI; Prism 6.0, GraphPad Software Inc., La Jolla, CA). P-values < .05 were considered significant.
| RE S U L TS
In the first phase of this project, clinicians (n 5 13) and technicians (n 5 3) completed a case-based quiz after training. Clinicians consisted of boarded-certified small animal specialists (n 5 6), residents (n 5 5), a rotating intern (n 5 1), and an internship-trained emergency veterinarian (n 5 1). Technicians were all licensed veterinary technicians.
Clinicians and technicians were able to correctly apply the DOGiBAT after training, scoring 100% of responses correctly.
In the second phase of this project, 70 veterinary students were administered the case-based quiz, after having been randomized to The odds of trained students giving correct answers were higher than those of untrained students (P < .0001). Numbers and percentages of correct scores from students with and without training at each anatomic site are shown in [757/945]; P 5 .015). When analyzed separately, training benefited students regardless of their class year, because training had a significant effect on correct scoring in both the third year (P 5 .02) and fourth year (P < .0001) veterinary students.
In the third phase of this project, the clinicians (n 5 13) trained in Outcome measures (administration of blood products, duration of hospitalization in days, and survival to discharge) were assessed in PI dogs and compared with non-PI (SI and NI) dogs ( (Tables S1 and S2 ).
| D ISC USSION
We developed and evaluated the DOGiBAT, an assessment tool to Numbers and percentages of dogs that received blood products during hospitalization and that survived to discharge are presented, along with hospital duration (median and range; days). Values for outcomes that are significantly different between PI and non-PI dogs (P < .05) are in bolded text.
hospitalization in dogs with primary ITP, demonstrating its potential prognostic value.
Immune thrombocytopenia is a common cause of severe thrombocytopenia in dogs, yet individuals with similar platelet counts display variable bleeding tendencies. The exact mechanisms for this bleeding
heterogeneity have yet to be determined. Mechanisms proposed in the human literature include differences in platelet activation, 17 interference of antibodies with platelet function, 18, 19 effects of anemia on platelet function, vascular endothelial abnormalities, 20 and presence of procoagulant microparticles. 21, 22 Clinical trials in ITP patients, therefore, require not only assessment of platelet count but also a metric of bleeding severity in order to consistently gauge disease severity and response to treatment.
We therefore developed the DOGiBAT as an objective system for scoring clinical bleeding in dogs with ITP. To our knowledge, only 1 prior bleeding score has been reported in the veterinary literature. It was used to score thrombocytopenic dogs in a clinical trial evaluating efficacy of various platelet transfusions, but the scoring system itself did not undergo thorough evaluation in that study. 23 Several bleeding scores are used to quantify bleeding in human ITP patients. The DOGi-BAT was modeled after the ITP Bleeding Scale (IBLS), a simple yet complete scoring system utilized in the human literature. 5 In 1 study of humans with ITP, the IBLS was reported to be associated with platelet count, but this association did not persist for patients with platelet counts < 30,000/lL, 5 likely because of the heterogeneity in clinical bleeding seen with severe thrombocytopenia. Since the initial description of the IBLS, several other publications in the human literature have implemented this bleeding score in ITP patients to make correlations between clinical bleeding severity and clinicopathologic variables [24] [25] [26] and to assess clinical bleeding in treatment trials. 27, 28 Although similar to the IBLS, several modifications tailor the DOGi-BAT to ITP in dogs. First, the DOGiBAT does not include grading of historical bleeding, as many canine ITP patients present with acute disease without a prior diagnosis of ITP. Similarly, grading of gynecological bleeding was not included, because the majority of female dogs diagnosed with ITP are spayed. 4, 6, 8, 29 Modifications were made to the oral cavity category, because dogs do not typically develop the blood blisters commonly seen in humans with ITP. Finally, a category was added to the DOGiBAT to account for bleeding after a minimally invasive procedure (eg, venipuncture).
The DOGiBAT was first evaluated with clinicians and technicians in referral practices by use of a case-based quiz utilizing details and images from clinical cases. These clinicians and technicians scored all cases correctly at all sites, demonstrating that the DOGiBAT was easy to employ correctly and consistently. Because the majority of clinicians given the case-based quiz after training were either board-certified specialists or residents receiving training in a small animal specialty, this population is likely representative of a referral institution, but may not represent the population of small animal veterinary practitioners as a whole. Further evaluation in a larger population of clinicians in all types of veterinary practices should be considered in future studies using the DOGiBAT.
The training module instructed users on implementation of the DOGiBAT scoring tool. To evaluate the effects of training, veterinary students were utilized as a large population of individuals who likely had less clinical experience than the clinicians in phase 1. Although students were not questioned or selected based on their clinical expertise, it is likely that the students varied in their prior exposure to small animal practice. However, students were randomized to receive the training module before taking the quiz to minimize any confounding effect of prior experience.
We found that students who received training scored more correct responses than those who had received no training. Scoring of 3 anatomic sites (oral cavity, ocular, and cutaneous) was most improved by having access to training. Because some bleeding grades are inherently easier to understand without training (eg, presence or absence of epistaxis) or require more diagnostic acumen (eg, funduscopic bleeding or hyphema), differences among categories were not unexpected. By providing the user a written definition and pictorial example of each bleeding grade at each anatomic site, the training course was able to clarify grading to improve correct scoring at challenging anatomic sites. We also determined that fourth year veterinary students scored more responses correctly compared with third year veterinary students, independent of their access to the training course. This observation is suspected to be a result of the clinical experience that fourth year veterinary students gain from their clinical rotations during their senior year. Although evaluated in a group of students, the training course will likely improve correct implementation of the DOGiBAT among more experienced clinicians as well.
In the third phase of this study, clinicians implemented the DOGi-BAT in clinical practice in a pilot study of dogs with thrombocytopenia.
Although the DOGiBAT was developed for use in canine ITP patients, dogs with thrombocytopenia of any underlying etiology were enrolled and we performed comparisons of bleed scores and platelet counts Spearman correlation coefficients (r s ) and P-values considered significant (P < .05) are in bolded text.
among all dogs and specifically for the target ITP population. Because 
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